Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Bank Central Asia Tbk (BBCA) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Bank Central Asia Tbk
Brigit Biofarmaka Teknologi Tbk.

Price performance

Price movement over the last 24 hours

Key statistics

Bank Central Asia Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Bank Central Asia Tbk trades at Rp6,225 (market cap 753.61T, 180.06M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp244 (market cap 164.65B, 214.9K 24h volume). The key difference: Bank Central Asia Tbk is far larger — about 4577× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Bank Central Asia Tbk is more actively traded (180.06M versus 214.9K). Which is the better fit depends on your goals.

BBCAOBAT
Market Cap
753.61T164.65B
Volume
180.06M214.9K
Lot
1.8M2.15K
Turnover
1.11T51.97M
Average Price
6,176.89241.85
Value
1.11T51.97M
Indicative Equilibrium Price
6,225240
Indicative Equilibrium Volume
292.85K100

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BBCA
View details
OBAT
View details

About Bank Central Asia Tbk

PT. Bank Central Asia, Tbk (the Company) was established under the name of N.V. Perseroan Dagang Dan Industrie Semarang Knitting Factory based on notarial deed No. 38 of Raden Mas Soeprapto dated 10 August 1955, which was then changed to PT Bank Central Asia based on notarial deed No. 144 of Ridwan Suselo dated 21 May 1974.

Read more on BBCA

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT